期刊文献+

B型钠尿肽对甲状腺功能亢进性心脏病的诊断和心功能状态评估的价值及意义 被引量:9

原文传递
导出
摘要 目的探讨血浆B型钠尿肽(BNP)水平对甲状腺功能亢进性心脏病患者诊断和心功能状态评估的价值及其与甲状腺功能的相关性。方法采用微粒酶免疫测定法检测35例单纯甲状腺功能亢进患者、54例甲状腺功能亢进性心脏病患者和30例健康对照者的血浆BNP、血游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和促甲状腺激素(TSH),同时采用NYHA标准对54例甲状腺功能亢进性心脏病患者进行分级。结果甲状腺功能亢进组和甲状腺功能亢进性心脏病组患者血甲状腺激素FT3、FT4明显高于对照组(P<0.01),TSH明显低于对照组(P<0.01);血浆BNP水平甲状腺功能亢进组与健康对照组比较无明显差别(P>0.05),甲状腺功能亢进性心脏病组与对照组和甲状腺功能亢进组比较明显升高(P<0.01)。甲状腺功能亢进性心脏病组患者的心功能Ⅰ、Ⅱ、Ⅲ、Ⅳ级血浆BNP水平有统计学差异(F=11.41,P<0.001)。以甲状腺功能亢进性心脏病组血浆BNP为阳性,对照及甲状腺功能亢进组为阴性绘制ROC曲线,得出血浆BNP296.0ng/L为临界值,诊断甲状腺功能亢进性心脏病的敏感性和特异性分别为92.6%和93.80%。血浆BNP水平与心功能分级呈正相关(r=0.691,P<0.01),与甲状腺激素FT3、FT4水平无显著相关性(P>0.05)。结论血浆BNP是诊断甲状腺功能亢进性心脏病和评估心功能分级的有效指标。
出处 《中华临床医师杂志(电子版)》 CAS 2012年第14期4048-4050,共3页 Chinese Journal of Clinicians(Electronic Edition)
基金 辽宁省科技计划项目(2011225019)
  • 相关文献

参考文献13

  • 1张麦叶,明洁,张南雁,高彬,姬秋和.血清B型钠尿肽测定在糖尿病早期左心功能不全诊断中的应用[J].中华临床医师杂志(电子版),2011,5(22):6549-6553. 被引量:6
  • 2谭丽玲.甲亢性心脏病患者血清脑纳肽浓度变化对左室功能的评价[J].中国热带医学,2011,11(4):499-500. 被引量:6
  • 3陈卫中,倪宗瓒,潘晓平,刘元元,夏彦.用ROC曲线确定最佳临界点和可疑值范围[J].现代预防医学,2005,32(7):729-731. 被引量:208
  • 4Sudoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain. Nature . 1988
  • 5Januzzi JL,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. European Heart Journal . 2006
  • 6Hamilton M A,Stevenson L W,Fonarow G C,et al.Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. The American Journal of Cardiology . 1998
  • 7Sahin M,Portakal O,Karagoz T,et al.Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies. Clinical Biochemistry . 2010
  • 8Nabbout LA,Robbins RJ.The cardiovascular effects of hyperthyroidism. Methodist Debakey Cardiovase J . 2010
  • 9Siu CW,Yeung CY,Lau CP, et al.Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism. Heart . 2007
  • 10Wei T,Zeng C,Tian Y, et al.B-type natriuretic peptide in patients with clinical hyperthyroidism. Journal of Endocrinological Investigation . 2005

二级参考文献26

  • 1随华,刘纯.脑钠肽与内分泌疾病[J].国际内分泌代谢杂志,2006,26(3):181-183. 被引量:11
  • 2倪长霖,张亚文,胡筱芸.2型糖尿病合并冠心病危险因素的临床研究[J].天津医药,2006,34(9):607-609. 被引量:19
  • 3戴江平,李茜,张家龙.血浆BNP变化与慢性心功能不全关系的研究[J].临床和实验医学杂志,2007,6(5):90-91. 被引量:6
  • 4刘新民.实用内分泌学[M].第三版,人民军医出版社,2004:215.
  • 5Abraham WT. Physiology and therapeutic implications of natriuretic peptides in heart failure[J]. Heart Fail, 1996,12:55-72.
  • 6KohnoM, HofioT, Yasun ariK,et al . Stimulation of brain natriuretic peptide release from the heart by thyroid hormone [J]. Metabolism,1993,42(8 ) : 1059-1063.
  • 7SchuhzM,Faber J,Kistorp C,et al. Nterminal proBtype natrluretie peptide (NT-pro-BNP) indifferent thyroid function states [J] . Clin Endocrinol(Oxf), 2004,60( 1 ) : 54-57.
  • 8Gregory Mark. Receiver-operating characteristic (ROC) plots: Fundamental Evaluation Tool in Clinical Medicine [ J ]. Clin Chem,1993, 30 (4): 561 - 567.
  • 9Hanley JA, McNeil BJ. The meaning and use of the area under a receiveroperating characteristic (ROC) curve [J]. Radiology, 1982,143 (4): 29.
  • 10Swets JA. Measuring the accuracy of dianostic system [J]. Science,1988, 240 (4622): 1285.

共引文献217

同被引文献57

  • 1陈昌,方林彬.不同甲状腺功能状态患者血浆B型钠尿肽的检测及其临床意义[J].广东医学院学报,2007,25(4):393-394. 被引量:4
  • 2叶任高,陆再英.内科学[M].6版.北京:人民卫生出版社,2005.948-987.
  • 3中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846
  • 4Heywood JT. Diagnostic and therapeutic uses of natriuretic pep-tides. Introduction[J]. Rev Cardiovasc Med, 2007,8 Suppl 5 : S1- 2.
  • 5Cantinotti M, Giovannini S, Murzi B, et at. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and relat- ed peptides in children with congenital heart diseases[J]. Clin Chem Lab Med,2011,49(4) :567-580.
  • 6Pandit K, Mukhopadhyay P, Ghosh S, et al. Natriuretie peptides: Diagnostic and therapeutic use [J]. Indian J Endocrinol Metab, 2011,15 Suppl 4 : S345-353.
  • 7Tort AD. Subclinical hyperthyroidism[J]. N Engl J Med, 2001, 345(7) :512-516.
  • 8Dickstein K. Natriuretic peptides in detection of heart failure[J]. Lancet, 1998,351(9095) :4.
  • 9Nabbout LA,Rohbins RJ. The cardiovascular effects of hyperthy- roidism[J]. Methodist Debakey Cardiovase J, 2010,6 (2) : 3-8.
  • 10Kohno M, Horio T, Yasunari K, et al. Stimulation of brain natri- uretic peptide release from the heart by thyroid hormone[J]. Me- tabolism, 1993,42 (8) : 1059-1064.

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部